Latest news

Find the latest news about Elanco and its products. Check our news archives for previous stories.

Media and general inquiries should be directed to:

Elanco Animal Health

2500 Innovation Way
Greenfield, IN 46140
1-800-428-4441 or 1-317-277-3185

Corporate news

Food news

Pet news

September 18, 2014

Elanco Animal Health and Dow AgroSciences Announce Strategic R&D Agreement

Elanco Animal Health and Dow AgroSciences Announce Strategic R&D Agreement
Agreement will focus on developing integrated solutions to enable livestock producers to increase meat and milk production to meet the demands of the growing global population.  

April 22, 2014

Elanco acquires Novartis Animal Health

Elanco announces an agreement to acquire Novartis Animal Health, creating a global leader in animal health innovation and customer value. The $5.4 billion deal creates world’s second-largest animal health company.

February 24, 2014

Elanco acquires Lohmann SE

Elanco announces an agreement to acquire Lohmann Animal Health, a privately-held company headquartered in Cuxhaven, Germany. The acquisition will establish Elanco as a global poultry leader, extending our presence into layers and expanding our growing vaccine presence.

February 16, 2012

Hygromix® returns to help poultry producers fight intestinal worms

Hygromix, an in-feed medication for control of parasite infections in chickens, will once again be available in the United States starting mid-April. Hygromix is the only FDA-approved poultry product that controls all three nematodes; capillary worms (Capillaria obsignata), cecal worms (Heterakis gallinae) and large roundworms (Ascaris galli), and is recommended for pullets and breeders.

  • For use as an aid in the control of parasite infections in chicken flocks associated with Ascaris galli, Heterakis gallinae and Capillaria obsignata.
  • Mix 1.0–1.5 lbs. Hygromix 8 per ton of Type C medicated feed for 8–12 g of hygromycin B per ton.
  • Feeds containing Hygromix must be withdrawn 3 days prior to slaughter.

The label contains complete use information, including cautions and warnings. Always read, understand and follow the label and use directions

August 24, 2012

Elanco Announces Comfortis® (spinosad) for Cats and Small Dogs

Comfortis® (spinosad), the month-long flavored tablet that has been protecting dogs from fleas since 2007 has now been approved for use in cats and smaller dogs. As a result of the recent FDA approval, Comfortis can now be used in cats and kittens greater than 2 lbs and 14 weeks and older. In addition, our new 90 mg tablet will allow veterinarians to prescribe Comfortis for smaller dogs 3.3-4.9 lbs and 14 weeks and older.

Important safety information

For cats: The most common adverse reaction recorded in clinical trials was vomiting. Other adverse reactions were: lethargy, decreased appetite, weight loss, and diarrhea. Use with caution with concomitant extra-label use of ivermectin.

The safe use of Comfortis in breeding, pregnant, or lactating cats has not been evaluated.

For dogs: The most common adverse reaction reported is vomiting. Other adverse reactions reported in decreasing order of frequency are: depression/lethargy, decreased appetite, incoordination, diarrhea, itching, trembling, excessive salivation and seizures.

Following concomitant extra-label use of ivermectin with Comfortis, some dogs have experienced the following clinical signs: trembling/twitching, salivation/ drooling, seizures, incoordination, excessive dilation of pupils, blindness and disorientation. Post-approval experience continues to support the safety of Comfortis when used concurrently with heartworm preventatives according to label directions.

Use with caution in breeding females and dogs with pre-existing epilepsy. The safe use of Comfortis in breeding males has not been evaluated.

View full product label for complete safety information